This information was published on 2025-06-17T14:54:16 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2555735 (IR 1859357) |
| (220) |
17 Apr 2025
|
| (300) |
US, 24 Oct 2024, 98818944
|
| (511) (510) |
Class 5
Antimicrobial preparations for inhibiting bacteria; drug delivery agents in the form of coated capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention of autoimmune, inflammatory, bacterial, and antibiotic-induced infectious conditions; pharmaceutical preparations for delivery of oxygen to tissue; therapeutic agents for delivery of oxygen to human tissue. Class 44 Medical diagnostic services; medical services in the field of antibiotic-induced infection and gastroenterology; providing information in the fields of health and wellness in the field of autoimmune conditions, inflammatory conditions, bacterial conditions, antibiotic-induced infectious conditions, and oxygen therapy via a website; providing medical information in the field of autoimmune conditions, inflammatory conditions, bacterial conditions, antibiotic-induced infectious conditions, and oxygen therapy. |
| (540) | SIDIPREV |
| (550) | Word |
| (730) |
LPOXY THERAPEUTICS, INC.
|
Find out more about publications on the About page.